VLIZ
VLAAMS INSTITUUT VOOR DE ZEE
MARIEN EN KUSTGEBONDEN ONDERZOEK & BELEID IN VLAANDEREN
   
© VLIZ © VLIZ © VLIZ © VLIZ © VLIZ
 
 
  English  Sitemap  Print
U bent hier: VLIZ > datacentrum
menu1 Over het VLIZ menu2 Infoloket menu3 Zeebibliotheek menu4 Cijfers&Beleid menu5 Faciliteiten menu6 Datacentrum
   
Datacentrum
  - IMIS: Integrated Marine Information System -
log in

Personen | Instituten | Publicaties | Projecten | Datasets | Kaarten
meld een fout in dit recordmandje (0): toevoegen | tonen Print-vriendelijke versie

Arenicola marina extracellular hemoglobin: a new promising blood substitutePeer reviewed article
Rousselot, M.; Delpy, E.; La Rochelle, C.D.; Lagente, V.; Pirow, R.; Rees, J.F.; Hagege, A.; Le Guen, D.; Hourdez, S.; Zal, F. (2006). Arenicola marina extracellular hemoglobin: a new promising blood substitute Biotechnol. J. 1(3): 333-345. dx.doi.org/10.1002/biot.200500049
In: Biotechnology Journal. Wiley-VCH: Weinheim. ISSN 1860-6768, meer

Beschikbaar in Auteurs 
    VLIZ: Open Repository 237090 [ OMA ]

Trefwoord
    Marien
Author keywords
    Blood substitute; Extracellular hexagonal bilayer hemoglobin; Annelid

Auteurs  Top 

Abstract
    The need to develop a blood substitute is now urgent because of the increasing concern over Europe's BSE outbreak and the worldwide HIV/AIDS epidemic, which have cut blood supplies. Extracellular soluble hemoglobin has long been studied for its possible use as a safe and effective alternative to blood transfusion, but this has met with little success. Clinical trials have revealed undesirable side effects–oxidative damage and vasoconstriction–that hamper the application of cellfree hemoglobin as a blood substitute. We have addressed these problems and have found a new promising extracellular blood substitute: the natural giant extracellular polymeric hemoglobin of the polychaete annelid Arenicola marina. Here we show that it is less likely to cause immunogenic response; its functional and structural properties should prevent the side effects often associated with the administration of extracellular hemoglobin. Moreover, its intrinsic properties are of interest for other therapeutic applications often associated with hemorrhagic shock (ischemia reperfusion, treatment of septic shock and for organ preservation prior to transplantation). Moreover, using natural hemoglobin is particularly useful since recombinant DNA techniques could be used to express the protein in large quantities.

 Top | Auteurs 
 

 

Vlaams Instituut voor de Zee
InnovOcean site
Wandelaarkaai 7
B-8400 OOSTENDE, België
Tel: +32 [0]59/34 21 30
Fax: +32 [0]59/34 21 31
Email: info@vliz.be
   

 

Vlaamse Gemeenschap Provincie West-Vlaanderen